pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/englezi/12 i...
TRANSCRIPT
![Page 1: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/1.jpg)
Pharmacogenetics Ch. 12
![Page 2: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/2.jpg)
![Page 3: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/3.jpg)
![Page 4: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/4.jpg)
![Page 5: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/5.jpg)
![Page 6: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/6.jpg)
![Page 7: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/7.jpg)
![Page 8: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/8.jpg)
![Page 9: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/9.jpg)
Monogenic diseases
Ch. 19
![Page 10: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/10.jpg)
Monogenic diseases
• Aberations of a single gene
• Inheritance dominant or recesive (autosomal or sex chromosome)
• Examples:
– Huntington
– Myotonic dystrophy
– Neurofibromatosis
– Marfan syndrom
– Cystic fibrosis
– Duchenne muscular dystrophy
– Hemophilia
![Page 11: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/11.jpg)
Huntington disease • 4p16 (Huntingtin, 1:10000), autosomal dominant with anticipation
• ↑ 40 polyglutamin (CAG ) repeats in 5’translated region
• Accumulation of huntingtin in neuronal aggregates - apoptosis
Preogressive movement disorder (chorea = involuntary movements); cognitive deterioration, possible dementia, psychiatric disorders
![Page 12: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/12.jpg)
Myotonic distrophy (MD) • 19q13 (3’UTR of DMPK mRNA), 50-2000 x CTG
• autosomal dominant with anticipation (1:8000)
• Interference with cellular processing of RNA
gain of function for binding CUG-BP
• Weakness and myotonia, progressive spasm with prolonged relaxation, cataract, cardiac conduct defects, …
• More distal mucles affected,
also digestive tract
Typ 2 MD
• 3q21 (ZNF9), 75-11000 x CCTG
• Proximal myotonic myopathy
![Page 13: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/13.jpg)
Neurofibromatosis • Mutation in NF gene (1 and 2) (17q11, neurofibromin, 1:3000)
• Autosomal dominant inheritance or de novo mutation (50%)
• Deletions, insertions, duplications and point substitutions: → truncaton or absence of tumor supressor neurofibromin protein
• Neurofibroms (benigne skin tumors), „cafe au lait” spots“, rarely mild mental retardation
• Possible epilepsy, CNS tumors, scoliosis
![Page 14: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/14.jpg)
Marfan syndrom
• Mutation in FBN1 (fibrillin type 1, 15q21)
• Autosomal dominant inheritance
• Fibrillin forms elastic fibers in connective tissue
• High stature, arachnodactylia, weeknes and flexibility of joints, underweight, thoracic deformation, scoliosis, lens ectopy, possibility of aortal dissection
![Page 15: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/15.jpg)
Cystic fibrosis • Mutation in CF gene(7q31) – cloride chanal
• Autosomal recessive trait (1: 2000 !)
• deletion (Phe508del), missense, frameshift, splicesite, nonsense,…
• “mucoviscidosis”- viscous secretion accumulation in lungs and pancreatic ducts, secundar cor pulmonale development
• complications: ileus, prolaps of rectum, infertility in males, cyrosis, diabetes
• Therapy: antibiotics, pulmonary drainage
![Page 16: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/16.jpg)
Duchene – muscular dystrophy • The most common and severest
type of distrophy (1: 3500 mail)
• X linked recessive trait
• Mutation in Xp21 (distrophin gene)
• Symptoms in early childhood: progressive muscle weekness, lumbal lordosis, pseudohypertrophy of calves, joints contractures
• Letal in early adolthood (usualy no offsprings)
• Woman carrier detection – serum creatine kinase measurement and genotypinga
![Page 17: Pharmacogenetics - neuron.mefst.hrneuron.mefst.hr/docs/katedre/imunologija/2016-17/Englezi/12 i 19... · • Autosomal dominant inheritance or de novo mutation (50%) • Deletions,](https://reader031.vdocuments.net/reader031/viewer/2022021809/5c0d8e7209d3f258548bae8d/html5/thumbnails/17.jpg)
Hemophilia • Hemofilia: A (1: 5000), B rare – X linked recessive trait
• coagulation factor 8 defficite (less than 1%)
• Mild to severe bleeding, joint hemorrhage
• Therapy: coagulation factor substitution by transfusions
• Gene therapy candidates
1819-1901.